Story perspectives

DOJ Blocks Missouri’s Challenge to Mifepristone Mail Shipment Rules

3/10/2026

Summary

Story summary

The Justice Department moved to block Missouri's lawsuit challenging rules by the U.S. Food and Drug Administration (FDA) allowing mail shipment of mifepristone.
DOJ argues the lawsuit could hinder a safety study.
Pro-life states, including Missouri, say the policy undermines their laws and risks women's health.
Critics say regulations enable abuse by allowing drug access without oversight.
Pro-life advocates criticize the filing and demand stricter regulations.

1 of 1

Story summary

The Justice Department moved to block Missouri's lawsuit challenging rules by the U.S. Food and Drug Administration (FDA) allowing mail shipment of mifepristone.
DOJ argues the lawsuit could hinder a safety study.
Pro-life states, including Missouri, say the policy undermines their laws and risks women's health.
Critics say regulations enable abuse by allowing drug access without oversight.
Pro-life advocates criticize the filing and demand stricter regulations.